Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 06 Jan 2026 for Mersana Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleAshish Mandelia
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Ashish Mandelia: trading record in brief
Ashish Mandelia (senior executive) discloses dealings in Mersana Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 1 July 2021 to 6 January 2026, the count stands at 9 filings.
No open-market purchase appears, only 1 sale worth €11k. The rest of the record consists of 7 option exercises.
The newest entry dates from 6 January 2026: a transaction, in Mersana Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Ashish Mandelia
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
2,300 sharesCommon StockSEC:0001104659-26-001375:0
4,519 shares0Common StockSEC:0001104659-25-004597:0
4,783 shares0Common StockSEC:0001104659-25-004185:0
2,646 shares0Common StockSEC:0001104659-25-003879:0
30,000 shares0Common StockSEC:0001104659-24-106748:0
2,645 shares0Common StockSEC:0001104659-24-004549:0
4,784 shares0Common StockSEC:0001104659-23-004743:0
5,353 sharesCommon StockSEC:0001104659-22-005555:0
942 shares@ US$13.60100.0% of flowCommon StockSEC:0001104659-21-088909:0
9 of 9 declarations
